Recovery Report: Atkore International Inc.?s Recovery Rating Profile Dec 11

  • ID: 2035063
  • December 2011
  • Region: Global
  • Standard & Poors
1 of 3


  • Atkore International Inc.
  • Tyco International Ltd.
  • MORE

We are updating our recovery analysis on U.S.-based metals fabricator Atkore International Inc.'s (Atkore) senior notes as part of our ongoing ratings surveillance process. Our recovery rating on the senior secured notes remains unchanged. We lowered the issue-level rating as a result of the one-notch downgrade of Atkore's corporate credit rating on Dec. 28, 2011. Our simulated default scenario assumes a default in 2014, due primarily to a prolonged, material downturn in the U.S. nonresidential construction industry. Our analysis and ratings reflect the following capital structure. The ABL facility is secured on a first-priority basis by the accounts receivable, inventory, cash, deposit accounts, and related current assets (ABL collateral) of Atkore and the guarantors, and on a second-priority basis by...

Companies mentioned in this report are:
- Tyco International Ltd.
- Atkore International Inc.

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- Tyco International Ltd.
- Atkore International Inc.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.